The keys to R&D: The rise of enterprise asset management in the pharma industry

Lorenzo Nanetti, Michael J. Desabris

Research output: Contribution to journalArticlepeer-review

Abstract

The pharmaceutical industry has proven to be a somewhat fortunate anomaly over the past few years. To its left and its right - in the financial sector, the manufacturing sector and the technology sector - an increasingly demoralising war has been waged against costs. Looking to every corner of infrastructure and operations, the world seemed to hinge on streamlining processes and fighting to gain an edge that would enable another quarter of survival, however fiscally static.

Original languageEnglish
Pages (from-to)8-11
Number of pages4
JournalEuropean Pharmaceutical Contractor
Issue numberSPRING
Publication statusPublished - Mar 2004

ASJC Scopus subject areas

  • Pharmaceutical Science

Fingerprint Dive into the research topics of 'The keys to R&D: The rise of enterprise asset management in the pharma industry'. Together they form a unique fingerprint.

Cite this